RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs
Journal of Cellular Biochemistry · 2024
DOI: 10.1002/jcb.30570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2024. Verfasst von Alex M Woodworth und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 2 Subunit, Promoter Regions, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: David Collins Leukaemia Foundation, Australian Research Council, National Health and Medical Research Council.
Abstract (Originalsprache)
Runt‐related transcription factor 1 (RUNX1) plays an important role in normal haematopoietic cell development and function, and its function is frequently disrupted in leukaemia. RUNX1 is widely recognised as a sequence‐specific DNA binding factor that recognises the motif 5′‐TG(T/C)GGT‐3′ in promoter and enhancer regions of its target genes. Moreover, RUNX1 fusion proteins, such as RUNX1‐ETO formed by the t (8;21) translocation, retain the ability to recognise and bind to this sequence to elicit atypical gene regulatory effects on bona fide RUNX1 targets. However, our analysis of publicly available RUNX1 chromatin immunoprecipitation sequencing (ChIP‐Seq) data has provided evidence challenging this dogma, revealing that this motif‐specific model of RUNX1 recruitment and function is incomplete. Our analyses revealed that the majority of RUNX1 genomic localisation occurs outside of promoters, that 20% of RUNX1 binding sites lack consensus RUNX motifs, and that binding in the absence of a cognate binding site is more common in promoter regions compared to distal sites. Reporter assays demonstrate that RUNX1 can drive promoter activity in the absence of a recognised DNA binding motif, in contrast to RUNX1‐ETO. RUNX1‐ETO supresses activity when it is recruited to promoters containing a sequence specific motif, while interestingly, it binds but does not repress promoters devoid of a RUNX1 recognition site. These data suggest that RUNX1 regulation of target genes occurs through multiple mechanisms depending on genomic location, the type of regulatory element and mode of recruitment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia.
- Faculty of Education, Science, Technology and Mathematics, Discipline of Biomedical Science, University of Canberra, Canberra, Australian Capital Territory, Australia.
- Menzies Institute for Medical Research, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia.
ORCID-Profile: Alex M Woodworth, Phillippa C Taberlay
Förderung
- David Collins Leukaemia Foundation
- Australian Research Council
- National Health and Medical Research Council
Zitieren
APA
Woodworth, A. M., Hardy, K., Taberlay, P. C., Dickinson, J. L., & Holloway, A. F. (2024). RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30570
Vancouver
Woodworth AM, Hardy K, Taberlay PC, Dickinson JL, Holloway AF. RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs. Journal of Cellular Biochemistry. 2024. doi:10.1002/jcb.30570
BibTeX
@article{Woodworth2024,
author = {Woodworth, Alex M and Hardy, Kristine and Taberlay, Phillippa C and Dickinson, Joanne L and Holloway, Adele F},
title = {RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs},
journal = {Journal of Cellular Biochemistry},
year = {2024},
doi = {10.1002/jcb.30570}
}
EUVIMED